Literature DB >> 28658197

Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.

Blake Nichols1, Sherri Kubis, Jennifer Hewlett, Nadir Yehya, Vijay Srinivasan.   

Abstract

OBJECTIVES: The 2012 Surviving Sepsis Campaign pediatric guidelines recommend stress dose hydrocortisone in children experiencing catecholamine-dependent septic shock with suspected or proven absolute adrenal insufficiency. We evaluated whether stress dose hydrocortisone therapy in children with catecholamine dependent septic shock correlated with random serum total cortisol levels and was associated with improved outcomes.
DESIGN: Retrospective cohort study.
SETTING: Non-cardiac PICU. PATIENTS: Critically ill children (1 mo to 18 yr) admitted between January 1, 2013, and December 31, 2013, with catecholamine dependent septic shock who had random serum total cortisol levels measured prior to potential stress dose hydrocortisone therapy.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The cohort was dichotomized to random serum total cortisol less than 18 mcg/dL and greater than or equal to 18 mcg/dL. Associations of stress dose hydrocortisone with outcomes: PICU mortality, PICU and hospital length of stay, ventilator-free days, and vasopressor-free days were examined. Seventy children with catecholamine-dependent septic shock and measured random serum total cortisol levels were eligible (16% PICU mortality). Although 43% (30/70) had random serum total cortisol less than 18 μg/dL, 60% (42/70) received stress dose hydrocortisone. Children with random serum total cortisol less than 18 μg/dL had lower severity of illness and lower Vasopressor Inotrope Scores than those with random serum total cortisol greater than or equal to 18 μg/dL (all p < 0.05). Children with stress dose hydrocortisone had higher severity of illness and PICU mortality than those without stress dose hydrocortisone (all p < 0.05). Mean random serum total cortisol levels were similar in children with and without stress dose hydrocortisone (21.1 vs 18.7 μg/dL; p = 0.69). In children with random serum total cortisol less than 18 μg/dL, stress dose hydrocortisone was associated with greater PICU and hospital length of stay and fewer ventilator-free days (all p < 0.05). In children with random serum total cortisol greater than 18 μg/dL, stress dose hydrocortisone was associated with greater PICU mortality and fewer ventilator-free days and vasopressor-free days (all p < 0.05).
CONCLUSIONS: Stress dose hydrocortisone therapy in children with catecholamine-dependent septic shock correlated more with severity of illness than random serum total cortisol levels and was associated with worse outcomes, irrespective of random serum total cortisol levels.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28658197      PMCID: PMC5581269          DOI: 10.1097/PCC.0000000000001237

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  40 in total

1.  Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Scott L Weiss; Thomas P Shanley; Michael T Bigham; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Jerry J Zimmerman
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

2.  Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: evidence of adrenal insufficiency?

Authors:  F A Riordan; A P Thomson; J M Ratcliffe; J A Sills; M J Diver; C A Hart
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

3.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuck Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

4.  A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids?

Authors:  Barry P Markovitz; Denise M Goodman; R Scott Watson; David Bertoch; Jerry Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

5.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

6.  Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial.

Authors:  Reid W D Farris; Noel S Weiss; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

7.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

8.  Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.

Authors:  Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

9.  Steroids in fluid and/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial.

Authors:  Katharine O'Hearn; Dayre McNally; Karen Choong; Anand Acharya; Hector R Wong; Margaret Lawson; Tim Ramsay; Lauralyn McIntyre; Elaine Gilfoyle; Marisa Tucci; David Wensley; Ronald Gottesman; Gavin Morrison; Kusum Menon
Journal:  Trials       Date:  2016-05-06       Impact factor: 2.279

10.  Reduced cortisol metabolism during critical illness.

Authors:  Eva Boonen; Hilke Vervenne; Philippe Meersseman; Ruth Andrew; Leen Mortier; Peter E Declercq; Yoo-Mee Vanwijngaerden; Isabel Spriet; Pieter J Wouters; Sarah Vander Perre; Lies Langouche; Ilse Vanhorebeek; Brian R Walker; Greet Van den Berghe
Journal:  N Engl J Med       Date:  2013-03-19       Impact factor: 91.245

View more
  5 in total

Review 1.  Medication and Fluid Management of Pediatric Sepsis and Septic Shock.

Authors:  Lauren Burgunder; Caroline Heyrend; Jared Olson; Chanelle Stidham; Roni D Lane; Jennifer K Workman; Gitte Y Larsen
Journal:  Paediatr Drugs       Date:  2022-03-21       Impact factor: 3.022

2.  The Association of Early Corticosteroid Therapy With Clinical and Health-Related Quality of Life Outcomes in Children With Septic Shock.

Authors:  Nicole N Kamps; Russell Banks; Ron W Reeder; Robert A Berg; Christopher J Newth; Murray M Pollack; Kathleen L Meert; Joseph A Carcillo; Peter M Mourani; Samuel Sorenson; James W Varni; Pelin Cengiz; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2022-06-10       Impact factor: 3.971

3.  Relation between Baseline Total Serum Cortisol Level and Outcome in Pediatric Intensive Care Unit.

Authors:  Osama E Bekhit; Shereen A Mohamed; Remon M Yousef; Hoiyda A AbdelRasol; Nirvana A Khalaf; Fatma Salah
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

4.  Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis.

Authors:  Katherine E Bline; Melissa Moore-Clingenpeel; Josey Hensley; Lisa Steele; Kristin Greathouse; Larissa Anglim; Lisa Hanson-Huber; Jyotsna Nateri; Jennifer A Muszynski; Octavio Ramilo; Mark W Hall
Journal:  Crit Care       Date:  2020-09-04       Impact factor: 9.097

5.  Dynamics and prognostic value of the hypothalamus-pituitary-adrenal axis responses to pediatric critical illness and association with corticosteroid treatment: a prospective observational study.

Authors:  Ilse Vanhorebeek; Greet Van den Berghe; An Jacobs; Inge Derese; Sarah Vander Perre; Pieter J Wouters; Sascha Verbruggen; Jaak Billen; Pieter Vermeersch; Gonzalo Garcia Guerra; Koen Joosten
Journal:  Intensive Care Med       Date:  2019-11-11       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.